Diabetes: Therapy for gestational diabetes mellitus--time for a change?

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Diabetes : Therapy for gestational diabetes mellitus--time for a change? / Damm, Peter; Mathiesen, Elisabeth R.

I: Nature Reviews Endocrinology, Bind 11, Nr. 6, 06.2015, s. 327-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Damm, P & Mathiesen, ER 2015, 'Diabetes: Therapy for gestational diabetes mellitus--time for a change?', Nature Reviews Endocrinology, bind 11, nr. 6, s. 327-8. https://doi.org/10.1038/nrendo.2015.54

APA

Damm, P., & Mathiesen, E. R. (2015). Diabetes: Therapy for gestational diabetes mellitus--time for a change? Nature Reviews Endocrinology, 11(6), 327-8. https://doi.org/10.1038/nrendo.2015.54

Vancouver

Damm P, Mathiesen ER. Diabetes: Therapy for gestational diabetes mellitus--time for a change? Nature Reviews Endocrinology. 2015 jun.;11(6):327-8. https://doi.org/10.1038/nrendo.2015.54

Author

Damm, Peter ; Mathiesen, Elisabeth R. / Diabetes : Therapy for gestational diabetes mellitus--time for a change?. I: Nature Reviews Endocrinology. 2015 ; Bind 11, Nr. 6. s. 327-8.

Bibtex

@article{beac9e1e836c415ba7bb140cd4c4c683,
title = "Diabetes: Therapy for gestational diabetes mellitus--time for a change?",
abstract = "For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.",
keywords = "Diabetes, Gestational, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy",
author = "Peter Damm and Mathiesen, {Elisabeth R}",
year = "2015",
month = jun,
doi = "10.1038/nrendo.2015.54",
language = "English",
volume = "11",
pages = "327--8",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "nature publishing group",
number = "6",

}

RIS

TY - JOUR

T1 - Diabetes

T2 - Therapy for gestational diabetes mellitus--time for a change?

AU - Damm, Peter

AU - Mathiesen, Elisabeth R

PY - 2015/6

Y1 - 2015/6

N2 - For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.

AB - For >30 years, insulin has been the drug of choice for the medical treatment of gestational diabetes mellitus. However, the use of oral hypoglycaemic agents has increased during the past 1–2 decades, so a recent comparison of treatment with glibenclamide, metformin or insulin in women with gestational diabetes mellitus is highly relevant.

KW - Diabetes, Gestational

KW - Female

KW - Glyburide

KW - Humans

KW - Hypoglycemic Agents

KW - Insulin

KW - Metformin

KW - Pregnancy

U2 - 10.1038/nrendo.2015.54

DO - 10.1038/nrendo.2015.54

M3 - Journal article

C2 - 25850660

VL - 11

SP - 327

EP - 328

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 6

ER -

ID: 154136837